A bolt behind your eyes, pressure in your temples… Maybe you’re one of the 10.5 million French people who suffer from headaches of varying severity throughout the year. And rest assured: you are not alone. According to a study published by very reputable Journal of Headaches and Pain (“Journal of Headaches and Pain” in French version) more than half of humanity experiences headaches over the course of a year. So today we will be 1.2 billion people aged 5 to over 65, according to the terms of the study, who need acetaminophen.
In particular, according to these researchers nNorwegians who arrived at these conclusions by immersing themselves in 60 years of study52% of the world’s population describe mainly tension headaches that feel like a vise around your head, but also regular migraines or, in the worst case, even headaches every other day.
>> Health: Music can relieve migraines
If headaches seem to have been on the rise since 1961 – however, the 357 publications collected do not allow this, as the numbers can vary widely – according to the Norwegian study led by Lars Jacob Stovner, Knut Hagen, Mattias Linde and Timothy J Steiner of the Norwegian University of Science and Technology, based in Trondheim, encourages scientists around the world to harmonize research to determine, for example, the influence of genetics, stress, light or more pollution on our migraines.
Also note the figure of 15.8%: This is the number of people in the world who suffer from headaches on a daily basis. According to experts, migraines are considered severe after eight crisis days per month. From 15 days of this disease considered neurological, it becomes chronic: about 1.4 million French would be affected by this last form.
The consequences in daily life are numerous, according to estimates by the association La Voix des Migraineux, 51% of working people are forced to stay away from work 90% of patients Difficulty looking after children and housing and that 15% of them have suicidal thoughts during migraine attacks.
To relieve migraines, there are treatments such as antidepressants, antihypertensives or antiepileptics that have been shown to be effective but can sometimes have side effects. New therapies have emerged in recent years: Four anti-CGRP antibodies — designed to block CGRP, a molecule implicated in migraines — are now marketed worldwide, including three in Europe and two in France, but they’re expensive : between 250 and 270 euros per piece per month.